Download
10571_2024_Article_1526.pdf 1,61MB
WeightNameValue
1000 Titel
  • Molecular Signaling Pathways of Quercetin in Alzheimer’s Disease: A Promising Arena
1000 Autor/in
  1. Alsaleem, Mansour A. |
  2. Al-kuraishy, Hayder M. |
  3. Al-Gareeb, Ali I. |
  4. Albuhadily, Ali K. |
  5. Alrouji, Mohammed |
  6. Yassen, Asmaa |
  7. Alexiou, Athanasios |
  8. Papadakis, Marios |
  9. Batiha, Gaber |
1000 Verlag Springer US
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-12-24
1000 Erschienen in
1000 Quellenangabe
  • 45(1):8
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s10571-024-01526-w |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11668837/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:p>Alzheimer’s disease (AD) is a neurodegenerative disease characterized by cognitive impairment and memory deficit. Even with extensive research and studies, presently, there is no effective treatment for the management of AD. Besides, most of drugs used in the treatment of AD did not avert the AD neuropathology, and the disease still in a progressive status. For example, acetyl cholinesterase inhibitors are associated with many adverse effects, such as insomnia and nightmares. As well, acetylcholinesterase inhibitors augment cholinergic neurotransmission leading to the development of adverse effects related to high acetylcholine level, such as salivation, rhinorrhea, vomiting, loss of appetite, and seizure. Furthermore, tacrine has poor bioavailability and causes hepatotoxicity. These commonly used drugs do not manage the original causes of AD. For those reasons, natural products were repurposed for the treatment of AD and neurodegenerative diseases. It has been shown that phytochemicals produce neuroprotective effects against the development and progression of neurodegenerative diseases by different mechanisms, including antioxidant and anti-inflammatory effects. Quercetin (QCN) has been reported to exert an effective neuroprotective effect against AD and other neurodegenerative diseases by lessening oxidative stress. In this review, electronic databases such as PubMed, Scopus, and Web of Science were searched for possible relevant studies and article linking the effect of QCN on AD. Findings from this review highlighted that many studies highlighted different mechanistic signaling pathways regarding the neuroprotective effect of QCN in AD. Nevertheless, the precise molecular mechanism of QCN in AD was not completely clarified. Consequently, this review aims to discuss the molecular mechanism of QCN in AD.</jats:p>
1000 Sacherschließung
lokal Quercetin
lokal Antioxidants/pharmacology [MeSH]
lokal Humans [MeSH]
lokal Alzheimer Disease/drug therapy [MeSH]
lokal Antioxidants/therapeutic use [MeSH]
lokal Neurodegenerative diseases
lokal Quercetin/therapeutic use [MeSH]
lokal Animals [MeSH]
lokal Molecular mechanism
lokal Neuroprotective effect
lokal Review Paper
lokal Alzheimer’s disease
lokal Oxidative stress
lokal Neuroprotective Agents/therapeutic use [MeSH]
lokal Quercetin/pharmacology [MeSH]
lokal Neuroprotective Agents/pharmacology [MeSH]
lokal Oxidative Stress/drug effects [MeSH]
lokal Signal Transduction/drug effects [MeSH]
lokal Alzheimer Disease/metabolism [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/QWxzYWxlZW0sIE1hbnNvdXIgQS4=|https://frl.publisso.de/adhoc/uri/QWwta3VyYWlzaHksIEhheWRlciBNLg==|https://frl.publisso.de/adhoc/uri/QWwtR2FyZWViLCBBbGkgSS4=|https://frl.publisso.de/adhoc/uri/QWxidWhhZGlseSwgQWxpIEsu|https://frl.publisso.de/adhoc/uri/QWxyb3VqaSwgTW9oYW1tZWQ=|https://orcid.org/0000-0002-7956-9739|https://orcid.org/0000-0002-2206-7236|https://frl.publisso.de/adhoc/uri/UGFwYWRha2lzLCBNYXJpb3M=|https://orcid.org/0000-0002-7817-425X
1000 Hinweis
  • DeepGreen-ID: 0706bcfcd6e84012a240c95b47b27e13 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Private Universität Witten/Herdecke gGmbH |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Private Universität Witten/Herdecke gGmbH |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6517595.rdf
1000 Erstellt am 2025-07-05T05:26:44.872+0200
1000 Erstellt von 322
1000 beschreibt frl:6517595
1000 Zuletzt bearbeitet 2025-08-19T19:23:29.266+0200
1000 Objekt bearb. Tue Aug 19 19:23:29 CEST 2025
1000 Vgl. frl:6517595
1000 Oai Id
  1. oai:frl.publisso.de:frl:6517595 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source